Contributions of Gamma-Aminobutyric Acid (GABA) Produced by Lactic Acid Bacteria on Food Quality and Human Health: Current Applications and Future Prospects.
Mehmet Arif IcerBuse SarikayaEmine KocyigitBüşra AtabilenMenşure Nur ÇelikRaffaele CapassoDuygu AğagündüzFerenc BudanPublished in: Foods (Basel, Switzerland) (2024)
The need to increase food safety and improve human health has led to a worldwide increase in interest in gamma-aminobutyric acid (GABA), produced by lactic acid bacteria (LABs). GABA, produced from glutamic acid in a reaction catalyzed by glutamate decarboxylase (GAD), is a four-carbon, non-protein amino acid that is increasingly used in the food industry to improve the safety/quality of foods. In addition to the possible positive effects of GABA, called a postbiotic, on neuroprotection, improving sleep quality, alleviating depression and relieving pain, the various health benefits of GABA-enriched foods such as antidiabetic, antihypertension, and anti-inflammatory effects are also being investigated. For all these reasons, it is not surprising that efforts to identify LAB strains with a high GABA productivity and to increase GABA production from LABs through genetic engineering to increase GABA yield are accelerating. However, GABA's contributions to food safety/quality and human health have not yet been fully discussed in the literature. Therefore, this current review highlights the synthesis and food applications of GABA produced from LABs, discusses its health benefits such as, for example, alleviating drug withdrawal syndromes and regulating obesity and overeating. Still, other potential food and drug interactions (among others) remain unanswered questions to be elucidated in the future. Hence, this review paves the way toward further studies.
Keyphrases
- human health
- risk assessment
- climate change
- lactic acid
- sleep quality
- escherichia coli
- amino acid
- depressive symptoms
- healthcare
- quality improvement
- metabolic syndrome
- type diabetes
- public health
- mental health
- emergency department
- weight loss
- current status
- gene expression
- spinal cord injury
- pain management
- adipose tissue
- weight gain
- skeletal muscle
- cerebral ischemia
- social media
- mass spectrometry
- atomic force microscopy
- genome wide
- room temperature
- case control
- high resolution
- high speed